Microbot Medical Inc.
MBOT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $146,691 | $91,950 | $25,699 | $19,061 |
| - Cash | $6,704 | $4,082 | $3,217 | $3,114 |
| + Debt | $899 | $149 | $138 | $111 |
| Enterprise Value | $140,886 | $88,017 | $22,620 | $16,058 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$10 | -$12 | $0 | -$26 |
| % Margin | – | – | – | – |
| EBITDA | -$3,567 | -$3,488 | -$3,006 | -$3,366 |
| % Margin | – | – | – | – |
| Net Income | -$3,577 | -$3,500 | -$2,601 | -$3,392 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.074 | -0.096 | 0.006 | -0.2 |
| % Growth | 22.4% | -1,672.1% | 103.1% | – |
| Operating Cash Flow | -$3,841 | -$2,573 | -$2,874 | -$1,691 |
| Capital Expenditures | -$13 | -$9 | -$13 | -$7 |
| Free Cash Flow | -$3,854 | -$2,582 | -$2,887 | -$1,698 |